Skip to main content
. 2022 Feb 2;15:687–700. doi: 10.2147/JIR.S351238

Table 2.

Relationship Between CVAI and New-Onset MI in Different Models

Variable Crude Model Adjusted Model 1 Adjusted Model 2 Adjusted Model 3
HR (95% CI) P-value HR (95% CI) P-value HR (95% CI) P-value HR (95% CI) P-value
CVAI (Per 1 SD increase) 1.65 (1.43, 1.90) <0.01 1.58 (1.35, 1.84) <0.01 1.56 (1.33, 1.83) <0.01 1.54 (1.28, 1.85) <0.01
Quartiles of CVAI
 Q1 Ref. Ref. Ref. Ref.
 Q2 1.30 (0.67, 2.50) 0.44 1.13 (0.58, 2.19) 0.72 1.15 (0.59, 2.25) 0.67 1.20 (0.61, 2.38) 0.59
 Q3 2.87 (1.64, 5.03) <0.01 2.49 (1.40, 4.43) <0.01 2.30 (1.29, 4.11) <0.01 2.45 (1.32, 4.55) <0.01
 Q4 4.80 (2.80, 8.24) <0.01 3.99 (2.25, 7.06) <0.01 3.76 (2.12, 6.64) <0.01 3.64 (1.94, 6.83) <0.01
P for trend <0.01 <0.01 <0.01 <0.01

Notes: Crude model: Unadjusted. Adjusted model 1: adjusted for age, gender, NC, BMI, DBP, SBP, history of diabetes, drinking status, and smoking status. Adjusted model 2: adjusted for all the variables in model 1, plus TG, TC, LDL-C, HDL-C, Lp (a), FPG, HsCRP, and Hcy. Adjusted model 3: adjusted for all the variables in model 2, plus antihypertensive drugs, lipid-lowering drugs, antiplatelet drugs, antidiabetic drugs, regular CPAP treatment, AHI, mean SaO2, and lowest SaO2.

Abbreviations: CI, confidence interval; HR, hazard ratio; other abbreviations as in Table 1.